These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 17923426

  • 1. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 2. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 3. The use of secondary medical prevention after primary vascular reconstruction: studies on usage and effectiveness.
    Høgh AL.
    Dan Med J; 2012 Sep; 59(9):B4514. PubMed ID: 22951205
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 5. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 6. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul 21; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 7. Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis.
    Setoguchi S, Glynn RJ, Avorn J, Mittleman MA, Levin R, Winkelmayer WC.
    J Am Coll Cardiol; 2008 Apr 01; 51(13):1247-54. PubMed ID: 18371553
    [Abstract] [Full Text] [Related]

  • 8. Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease.
    Sigvant B, Wiberg-Hedman K, Bergqvist D, Rolandsson O, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb 01; 16(1):39-46. PubMed ID: 19237996
    [Abstract] [Full Text] [Related]

  • 9. Medication in relation to ST-segment elevation myocardial infarction in patients with a first myocardial infarction: Swedish Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Björck L, Wallentin L, Stenestrand U, Lappas G, Rosengren A.
    Arch Intern Med; 2010 Aug 09; 170(15):1375-81. PubMed ID: 20696964
    [Abstract] [Full Text] [Related]

  • 10. Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting.
    Spencer FA, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ.
    Am Heart J; 2007 Jan 09; 153(1):140-6. PubMed ID: 17174652
    [Abstract] [Full Text] [Related]

  • 11. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.
    Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362
    [Abstract] [Full Text] [Related]

  • 12. Organising a nurse-driven PAD rehabilitation clinic within the vascular surgical department: what is required and are treatment goals reached--a prospective study?
    Sillesen H, Madelung S, Eldrup N, Roed M.
    Eur J Vasc Endovasc Surg; 2007 Jan 01; 33(1):26-32. PubMed ID: 17070079
    [Abstract] [Full Text] [Related]

  • 13. Medication underuse during long-term follow-up in patients with peripheral arterial disease.
    Hoeks SE, Scholte op Reimer WJ, van Gestel YR, Schouten O, Lenzen MJ, Flu WJ, van Kuijk JP, Latour C, Bax JJ, van Urk H, Poldermans D.
    Circ Cardiovasc Qual Outcomes; 2009 Jul 01; 2(4):338-43. PubMed ID: 20031859
    [Abstract] [Full Text] [Related]

  • 14. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr 01; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 15. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 01; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 16. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 01; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 17. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar 01; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 18. Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization.
    Tuppin P, Neumann A, Danchin N, de Peretti C, Weill A, Ricordeau P, Allemand H.
    Arch Cardiovasc Dis; 2010 Mar 01; 103(6-7):363-75. PubMed ID: 20800800
    [Abstract] [Full Text] [Related]

  • 19. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 01; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 20. [Management of the cardiology patient with polyvascular disease: PRISMA study].
    Cournot M, Cambou JP, Ferrières J, Grenier O, Herrmann MA, Cantet C, Leizorovicz A.
    Arch Mal Coeur Vaiss; 2004 Sep 01; 97(9):841-8. PubMed ID: 15521475
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.